CollPlant Biotechnologies Ltd (CLGN) Return on equity 2018–2025
CollPlant Biotechnologies Ltd (CLGN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-188.9%FY2025 · since FY2018: -115.3% → -188.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -188.9% | -65.6 pp |
| FY2024 | -123.3% | -98.6 pp |
| FY2023 | -24.8% | +27.7 pp |
| FY2022 | -52.4% | -53.0 pp |
| FY2021 | 0.5% | +129.5 pp |
| FY2020 | -129.0% | +144.1 pp |
| FY2019 | -273.1% | -157.8 pp |
| FY2018 | -115.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CLGN financial trends
CLGN RevenueCLGN Net incomeCLGN Net marginCLGN Gross profitCLGN Gross marginCLGN Operating incomeCLGN Operating marginCLGN Operating cash flowCLGN Free cash flowCLGN Capital expendituresCLGN Stock buybacksCLGN Dividends paidCLGN Total assetsCLGN Total liabilitiesCLGN Shareholders’ equityCLGN overview →